Kawase, Kazumi, Kazuhiko Yoshida, Keigo Hara, Suguru Hidaka, and Hiroshi Takeyama. 2023. “Efficacy and Safety of Neoadjuvant Chemotherapy With Dose De-Escalation Tri-Weekly Nanoparticle Albumin-Bound Paclitaxel and FEC for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer”. Clinical Medicine Insights 4 (2):378-86. https://doi.org/10.52845/CMI/2023-4-2-1.